TELA Bio TELA Income Statement (2018-2026)

NASDAQ TELA
$0.88 -0.03 (-3.80%)
As of: Sep 10, 2026 · 11:37 AM EDT
Reported Financials

TELA Bio Quarterly Income Statement

Periods 32 quarters
Latest Jun 2026

TELA Bio reported revenue of $19.29M and net income of -$11.26M for the quarter ended Jun 2026, down 4.5% year over year. This income statement covers 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
7.65M8.37M8.23M10.41M11.16M11.62M11.91M14.49M15.05M17.00M16.60M16.09M18.96M17.65M18.52M20.20M20.69M20.87M19.06M19.29M
Cost of RevenueCost of Rev
2.98M2.64M3.16M3.32M3.75M3.35M3.92M4.20M4.57M5.28M5.17M4.92M6.00M6.33M5.91M6.00M6.62M7.02M6.44M5.25M
Gross Profit
4.60M5.66M5.00M6.55M7.32M8.18M7.90M10.20M10.39M11.62M11.34M11.07M12.86M11.22M12.51M14.11M13.97M13.76M12.52M13.94M
Operating items
Amortization - Intangibles
0.08M0.08M0.08M0.54M0.10M0.10M0.10M0.10M0.10M0.12M0.10M0.10M0.10M0.12M0.10M0.10M0.10M0.12M0.10M0.10M
Research & DevelopmentR&D
6.95M8.31M9.38M11.05M11.17M11.65M13.47M14.58M14.47M17.16M17.52M16.70M16.47M13.96M16.61M16.86M15.23M14.49M16.54M16.44M
Selling, General & AdministrativeSG&A
3.46M3.27M3.46M3.63M3.53M3.24M3.63M3.47M3.73M4.05M3.83M3.62M3.68M3.59M3.84M4.13M3.95M3.78M4.17M4.06M
Restructuring CostsRestructuring
1.81M1.78M1.80M1.83M1.89M2.16M2.11M2.08M2.14M2.06M
Other Operating ExpensesOther Opex
1.41M1.73M2.01M2.10M2.10M2.73M2.05M2.51M2.37M2.69M7.58M0.66M0.04M0.24M0.04M0.20M0.66M
Operating ExpensesOpex
11.82M13.31M14.84M16.79M16.81M17.61M19.15M20.56M20.57M23.90M23.74M22.64M22.22M19.57M22.98M23.19M21.52M20.40M23.05M23.23M
Operating IncomeOp. Inc
-7.22M-7.65M-9.84M-10.24M-9.49M-9.44M-11.25M-10.36M-10.18M-12.28M-4.83M-11.57M-9.37M-8.35M-10.47M-9.08M-7.55M-6.65M-10.53M-9.28M
EBIT
-7.22M-7.65M-9.84M-10.24M-9.49M-9.44M-11.25M-10.36M-10.18M-12.28M-4.83M-11.57M-9.37M-8.35M-10.47M-9.08M-7.55M-6.65M-10.53M-9.28M
Non-operating items
Non Operating Interest Expenses
0.92M0.92M0.91M0.93M1.03M1.17M1.25M1.30M1.33M1.34M1.33M1.33M1.34M1.28M1.22M1.19M1.20M1.64M2.05M2.08M
Other Non Operating IncomeOther Non Op Inc.
-0.13M-0.04M-0.11M-1.23M-0.20M0.47M0.87M0.56M0.73M0.50M0.30M0.34M0.28M0.48M0.38M0.15M0.28M0.37M0.16M
Non Operating IncomeNon Op. Inc.
-1.05M-0.96M-1.02M-2.50M-1.23M-0.54M-0.77M-0.43M-0.78M-0.61M-0.83M-1.03M-1.01M-1.00M-0.74M-0.81M-1.05M-2.25M-1.69M-1.92M
Net income details
EBT
-8.14M-8.58M-10.76M-11.17M-10.52M-10.61M-12.50M-11.66M-11.52M-13.62M-5.66M-12.60M-10.37M-9.97M-11.21M-9.89M-8.60M-9.45M-12.21M-11.20M
Tax ProvisionsTaxes
0.05M0.03M-8.19M0.06M0.06M
Profit After TaxPAT
-8.27M-8.62M-10.86M-12.74M-10.71M-9.98M-12.06M-10.83M-10.96M-12.93M-5.66M-12.60M-10.37M-9.21M-11.26M-9.92M-8.61M-9.04M-12.28M-11.26M
Income from Continuing OperationsIncome (Continuing)
-8.14M-8.58M-10.76M-11.17M-10.52M-10.61M-12.50M-11.66M-11.52M-13.62M-5.66M-12.60M-10.37M-9.97M-11.26M-9.92M-8.60M-1.26M-12.27M-11.26M
Consolidated Net IncomeConsol Net Inc.
-8.14M-8.58M-10.76M-11.17M-10.52M-10.61M-12.50M-11.66M-11.52M-13.62M-5.66M-12.60M-10.37M-9.97M-11.26M-9.92M-8.60M-1.26M-12.27M-11.26M
Income towards Parent CompanyParent Net Inc
-8.14M-8.58M-10.76M-11.17M-10.52M-10.61M-12.50M-11.66M-11.52M-13.62M-5.66M-12.60M-10.37M-9.97M-11.26M-9.92M-8.60M-1.26M-12.27M-11.26M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-8.14M-8.58M-10.76M-11.17M-10.52M-10.61M-12.50M-11.66M-11.52M-13.62M-5.66M-12.60M-10.37M-9.97M-11.26M-9.92M-8.60M-1.26M-12.27M-11.26M
Additional items
EPS (Basic)
-0.56-0.59-0.74-0.77-0.63-0.65-0.65-0.50-0.47-0.60-0.23-0.51-0.42-0.35-0.25-0.22-0.19-0.03-0.21-0.20
EPS (Diluted)
-0.56-0.59-0.74-0.77-0.63-0.65-0.65-0.50-0.47-0.60-0.23-0.51-0.42-0.35-0.25-0.22-0.19-0.03-0.21-0.20
Shares Outstanding
14.49M14.47M14.54M14.56M16.76M16.27M19.19M23.24M24.48M22.87M24.58M24.66M24.70M28.53M45.27M45.37M45.42M46.95M57.26M57.41M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
14.49M14.47M14.54M14.56M16.76M16.27M19.19M23.24M24.48M22.87M24.58M24.66M24.70M28.53M45.27M45.37M45.42M46.95M57.26M57.41M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
14.50M14.53M14.56M14.56M19.16M19.17M19.23M24.48M24.49M24.49M24.65M24.68M24.72M28.53M39.55M39.58M40.34M44.54M57.26M57.41M
EBITDA
-7.22M-7.65M-9.84M-10.24M-9.49M-9.44M-11.25M-10.36M-10.18M-12.28M-4.83M-11.57M-9.37M-8.35M-10.47M-9.08M-7.55M-6.65M-10.53M-9.28M
Interest ExpensesInt Expense
0.92M0.92M0.91M0.93M1.03M1.17M1.25M1.30M1.33M1.34M1.33M1.33M1.34M1.28M1.22M1.19M1.20M1.64M2.05M2.08M
Tax Rate
-0.46%-0.33%86.65%-0.49%-0.54%